Tags

Tzur Gueta

פעילות כוחות צה"ל, כחלק ממבצע "מרכבות גדעון" ברצועת עזה
Combat service in IDF increases risk of ALS, Israeli study finds
New study reveals combat veterans, particularly IDF paratroopers, face a 2.5 times higher risk of degenerative illness, suggesting links to intense physical demands or environmental factors
Tzur Gueta | 05.22.25
סמים
War drives up recreational drug use in Israel, health experts warn
European study shows rise in amphetamine use since 2016; Israeli expert says no point in telling users 'just say no' as many connect increased drug use to emotional distress
Tzur Gueta | 05.19.25
Teal Wand
US approves at-home cervical cancer test; Israeli pilot programs underway
FDA’s approval of the Teal Wand, a self-sampling HPV test, marks a shift toward accessible cervical cancer screening, with Israeli HMOs piloting similar programs
Tzur Gueta | 05.16.25
נשיקה
Celiac disease patients can kiss without gluten exposure risk, study says
Researchers from Columbia and Stanford find that in most instances, the amount of gluten transferred during a kiss — even after eating gluten-rich crackers — was far below the threshold needed to trigger a reaction in celiac patients
Tzur Gueta | 05.10.25
פעילות כוחות חטיבה 188 במרחב רפיח
One in eight IDF reservists reports PTSD after Gaza war, study shows
Tel Aviv University research finds 12% of reservists report PTSD symptoms following combat engagements, up sharply from pre-war levels; researchers urge urgent action to expand mental health care and long-term support for combat veterans
Tzur Gueta | 05.07.25
פעילות יחידה 669 בלב עזה
Israeli researchers develop breakthrough treatment for life-threatening blood loss
Hebrew University and IDF Medical Corps researchers unveil breakthrough treatment for hemorrhagic shock, boosting survival, stabilizing vital signs and protecting tissues—promising for both civilian trauma care and battlefield use
Tzur Gueta | 05.06.25
פרופ' וולף וד"ר תמי רובינק
Breakthrough treatment slows brain metastases in colon cancer patients
Researchers at Sourasky Medical Center discover IRS2 protein helps cancer cells survive in brain’s hostile environment; new experimental drug combined with chemotherapy successfully reduced metastases in mice, offering hope for innovative treatments
Tzur Gueta | 05.06.25
לחץ במהלך ההיריון
Study finds maternal stress during pregnancy programs newborns' stress responses
A groundbreaking study from Hebrew University shows maternal stress during pregnancy can reprogram key molecular pathways in newborns, with significant differences between male and female infants
Tzur Gueta | 05.02.25
מימין: ד"ר דיאנה דרגו-גרסיה. משמאל: פרופ' יוסף ירדן
Israeli experts shed light on how breast cancer cells go dormant, return more aggressive
New study held at Weizmann Institute of Science uncovers the role of OVOL proteins and free radicals in breast cancer dormancy, offering insights into preventing relapse and tackling aggressive recurrence
Tzur Gueta | 05.01.25
Previous Articles
Hot Tags
Today
This Week
This Month
Judicial reformAhmad al-SharaaAirstrikeAmsterdamAntisemitismAriel BibasBenjamin NetanyahuBitcoinClimate crisisColumbia University
Hot Tags
Today
This Week
This Month
Judicial reformAhmad al-SharaaAirstrikeAmsterdamAntisemitismAriel BibasBenjamin NetanyahuBitcoinClimate crisisColumbia University
Related Tags
""